Organisation paid for research Program year 2025 Source: CMS Open Payments

Virginia Mason Med Ctr

Neither a doctor nor a teaching hospital

Research payments

$27,503

30 payments

Through program year 2025, Virginia Mason Med Ctr is reported as receiving $27,503 in research payments, across 30 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$22,200	1
2023	Research	$1,227	2
2019	Research	$4,076	27

Breakdown

Who paid Research payments · program years 2019–2025

AstraZeneca Pharmaceuticals LP $26,127 4 payments
Incyte Corporation $1,376 26 payments

Studies the money was for Research payments · program years 2019–2025

A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function $22,200 1 payment
An Open Label Non randomized Prospective Biomarker Study to Assess Analytic Concordance Between Non invasive Testing and Tissue Testing for EGFR T790M Mutation Detection in Patients With Non small Cell Lung Cancer $2,699 1 payment
Study of MEDI4736 Durvalumab With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer $1,227 2 payments
A Phase 3, Open Label, Randomized, Active Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Gemcitabine Plus Cisplatin Chemotherapy in First Line Treatment of Participants With Unresectable or Metastatic Cholangiocarcinoma With FGFR2 Rearrangement FIGHT 302 $1,044 25 payments
Prospective, Non Interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic Or Community Clinical Practices $332 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.